Pharma Deals Review, Vol 2005, No 56 (2005)

Font Size:  Small  Medium  Large

GSK Transfers Levitra® Co-Promotion Rights Back to Bayer

Business Review Editor

Abstract


GlaxoSmithKline (GSK) is to sell the marketing rights of Levitra® (vardenafil), a male impotence drug back to Bayer for €208 M. The companies co-promote the drug in Italy, where Bayer markets it as Levitra and GSK as Vivanza®.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.